Effect of Ascorbic Acid on Desferrioxamine-Induced Urinary Iron Excretion in Idiopathic Hemochromatosis
- 1 January 1984
- journal article
- research article
- Published by S. Karger AG in Acta Haematologica
- Vol. 72 (2) , 117-120
- https://doi.org/10.1159/000206370
Abstract
The effect on urinary Fe excretion (UIE) of vitamin C administered orally 2 h after the start of an 8 h deferrioxamine (DF) i.v. infusion was studied in 12 patients with untreated idiopathic hemochromatosis (IH). Mean .+-. SEM [standard error of the mean] basal UIE of 324.6 .+-. 84.6 .mu.g/24 h increased after a 1 g i.v. DF infusion of 8778.5 .+-. 1191.4 .mu.g/ 24 h; when vitamin C 1 or 2 g were added to DF i.v. infusion, there were further increases to 11,241.5 .+-. 1486.1 (P < 0.01) and 13,531.2 .+-. 1697.2 .mu.g/24 h (P < 0.05 vs. the last value), respectively. Basal UIE did not significantly increase after oral vitamin C administration alone. No side effects were observed.This publication has 5 references indexed in Scilit:
- FERRIOXAMINE EXCRETION IN IRON-LOADED MAN1982
- IMPROVEMENT IN IRON STATUS AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD WITH LONG-TERM SUBCUTANEOUS DESFERRIOXAMINEThe Lancet, 1979
- Ascorbic Acid Status in Idiopathic HemochromatosisDigestion, 1978
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- EFFECT OF DOSE, TIME, AND ASCORBATE ON IRON EXCRETION AFTER SUBCUTANEOUS DESFERRIOXAMINEThe Lancet, 1977